Analysts forecast that Ducommun Incorporated (NYSE:DCO) will report $145.15 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for Ducommun’s earnings. The highest sales estimate is $147.29 million and the lowest is $143.00 million. Ducommun reported sales of $142.49 million during the same quarter last year, which indicates a positive year over year growth rate of 1.9%. The business is scheduled to issue its next quarterly earnings results on Monday, March 5th.
On average, analysts expect that Ducommun will report full year sales of $145.15 million for the current year, with estimates ranging from $558.93 million to $563.22 million. For the next year, analysts expect that the business will post sales of $584.73 million per share, with estimates ranging from $584.46 million to $585.00 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that follow Ducommun.
Ducommun (NYSE:DCO) last issued its quarterly earnings results on Wednesday, November 1st. The aerospace company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.38 by $0.03. Ducommun had a net margin of 2.40% and a return on equity of 7.20%. The firm had revenue of $138.70 million for the quarter, compared to analysts’ expectations of $143.72 million. During the same period in the previous year, the business earned $0.44 earnings per share. Ducommun’s revenue for the quarter was up 4.6% compared to the same quarter last year.
In other Ducommun news, Director Anthony J. Reardon sold 30,000 shares of Ducommun stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $26.04, for a total transaction of $781,200.00. Following the transaction, the director now owns 82,603 shares of the company’s stock, valued at approximately $2,150,982.12. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Stephen G. Oswald bought 10,000 shares of the stock in a transaction on Monday, November 6th. The shares were acquired at an average cost of $27.39 per share, for a total transaction of $273,900.00. Following the purchase, the chief executive officer now owns 65,700 shares in the company, valued at $1,799,523. The disclosure for this purchase can be found here. Company insiders own 8.20% of the company’s stock.
Large investors have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC grew its stake in Ducommun by 169.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,400 shares of the aerospace company’s stock valued at $107,000 after acquiring an additional 2,140 shares in the last quarter. Macquarie Group Ltd. purchased a new position in Ducommun during the 3rd quarter valued at about $223,000. Alliancebernstein L.P. purchased a new position in Ducommun during the 2nd quarter valued at about $221,000. Mackenzie Financial Corp purchased a new position in Ducommun during the 3rd quarter valued at about $229,000. Finally, First Trust Advisors LP purchased a new position in Ducommun during the 3rd quarter valued at about $261,000. 82.44% of the stock is currently owned by institutional investors.
Ducommun (DCO) opened at $29.28 on Friday. The firm has a market capitalization of $325.68, a PE ratio of 25.03 and a beta of 0.81. Ducommun has a 12 month low of $25.06 and a 12 month high of $35.58. The company has a debt-to-equity ratio of 0.99, a current ratio of 2.46 and a quick ratio of 1.06.
ILLEGAL ACTIVITY WARNING: This report was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/01/27/ducommun-incorporated-dco-expected-to-post-quarterly-sales-of-145-15-million.html.
Ducommun Company Profile
Ducommun Incorporated is a global provider of engineering and manufacturing services for various products and failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. The Company is a solution-based provider, offering a range of value-added products and services in its primary businesses of electronics, structures and integrated solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ducommun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun and related companies with MarketBeat.com's FREE daily email newsletter.